DSIJ Mindshare

Cipla’s first-line triple-combination treatment for HIV receives approval from the South African Health Products Regulatory Authority (SAHPRA). The newly developed combination drug will be produced locally for the African market.

Narayana Hrudayalaya’s step-down subsidiary, NH Health Bangladesh, has entered into definitive agreements to partner with Imperial Hospital in Chittagong, Bangladesh to operate and manage their cardiac sciences department.

Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore.

Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore.

Another PSU, Ircon International, is set for the IPO which will open for subscription from September 17 to September 19, 2018. The issue consists purely of Offer for Sale (OFS) with 99,05,157 equity shares worth Rs 470.49 crore. The face value of the share is Rs 10 per share. The minimum lot size consists of 30 shares. The issue price per equity share is in range of Rs 470-475. Post allotment, the company will get listed on both BSE and NSE.